Stephen Hahn
Nucleus RadioPharma was founded in 2022 through a partnership with Mayo Clinic and Eclipse to ensure that the promise of new drugs for radioligand therapy reach the cancer patient.
To do this, Nucleus is building the world’s first fully integrated manufacturing, supply chain, and clinical operations company focused specifically on radiopharmaceuticals and theranostics.
It is the first fully integrated solution enabling our partners to design, test, and scale production of new radiopharmaceuticals, drive successful trials, secure distribution and redundancy, and reduce delays from order to final delivery that will meet the needs of the medical community, all within the same ecosystem.
A hot cell is a heavily shielded nuclear radiation containment chamber. Because the materials being processed emit high-energy ionizing radiation, these cells act as a barrier to protect technicians and the surrounding environment. This specialized line is used in nuclear medicine for the safe handling and production of radiopharmaceuticals for diagnostics and treatments.
